TE
TechEcho
Home24h TopNewestBestAskShowJobs
GitHubTwitter
Home

TechEcho

A tech news platform built with Next.js, providing global tech news and discussions.

GitHubTwitter

Home

HomeNewestBestAskShowJobs

Resources

HackerNews APIOriginal HackerNewsNext.js

© 2025 TechEcho. All rights reserved.

Drug giants Novartis and Bayer fail to stop NHS offering cheaper eye treatment

80 pointsby cirrus-cloudsover 6 years ago

4 comments

olvar_over 6 years ago
Where I live doctors are only allowed to give prescriptions for the generic chemical compound and are forbidden to give prescriptions for specific brands. They may suggest the use of a particular brand if they know of a benefit over others but the one who decides is the patient. Of course this is not very useful when the drug is patented or if there is only one laboratory producing it, but none the less it seems like a sane default. And this is in a private healthcare system, it is surprising that the NHS doesn't have a rule like this when is their taxpayer's money being used.
评论 #18043116 未加载
评论 #18043026 未加载
btianover 6 years ago
I don&#x27;t understand their arguments. Do they have proof that their licensed drugs are safer and&#x2F;or more effective than the replacement?<p>The article says &quot;In January, the National Institute for Health and Care Excellence (NICE) concluded that Avastin was as safe and effective as the two licensed drugs, Lucentis and Eylea.&quot;<p>If they have no proof, they should stfu.
评论 #18043512 未加载
pkayeover 6 years ago
Suddenly drug companies don&#x27;t want off-label use when it doesn&#x27;t suit them...
mirchisethover 6 years ago
This debate has happened in the US for many years. Here is a wsj article from 2011 <a href="https:&#x2F;&#x2F;www.wsj.com&#x2F;articles&#x2F;SB10001424052748704463804576291572903925578" rel="nofollow">https:&#x2F;&#x2F;www.wsj.com&#x2F;articles&#x2F;SB10001424052748704463804576291...</a>